Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Gilbert

Showing results (1161-1170 of 1,457) with videos related to

Pageof 146
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2006
Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variationLuo Wang, Qingyi Wei, Li-E Wang, et al.
Oncotarget|May 10, 2014
Anti-vascular endothelial growth factor therapy-induced glioma invasion is associated with accumulation of Tie2-expressing monocytesKonrad Gabrusiewicz, Dan Liu, Nahir Cortes-Santiago, et al.
The Journal of Clinical Investigation|June 6, 2007
The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal developmentYing Wang, Chao Wan, Lianfu Deng, et al.
Human Molecular Genetics|August 9, 2020
DOCK3 is a dosage-sensitive regulator of skeletal muscle and Duchenne muscular dystrophy-associated pathologiesAndrea L Reid, Yimin Wang, Adrienne Samani, et al.
Neuro-Oncology|March 12, 2015
Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627)Andrew B Lassman, Stephanie L Pugh, Mark R Gilbert, et al.
Nature Genetics|December 18, 2001
Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21Rachel V Baxter, Kamel Ben Othmane, Julie M Rochelle, et al.
Neuro-Oncology|January 30, 2021
Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825)Jeffrey S Wefel, Terri S Armstrong, Stephanie L Pugh, et al.
American Journal of Medical Genetics|July 18, 2000
Three probands with autistic disorder and isodicentric chromosome 15C M Wolpert, M M Menold, M P Bass, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|May 3, 2008
Refinement of 2q and 7p loci in a large multiplex NTD familyDemetra S Stamm, Deborah G Siegel, Lorraine Mehltretter, et al.
Cancers|January 16, 2020
Inhibition of PP2A with LB-100 Enhances Efficacy of CAR-T Cell Therapy Against GlioblastomaJing Cui, Herui Wang, Rogelio Medina, et al.
Pageof 146

Showing results (1161-1170 of 1,457) with videos related to

Sort By:
Pageof 146
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2006
Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variationLuo Wang, Qingyi Wei, Li-E Wang, et al.
Oncotarget|May 10, 2014
Anti-vascular endothelial growth factor therapy-induced glioma invasion is associated with accumulation of Tie2-expressing monocytesKonrad Gabrusiewicz, Dan Liu, Nahir Cortes-Santiago, et al.
The Journal of Clinical Investigation|June 6, 2007
The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal developmentYing Wang, Chao Wan, Lianfu Deng, et al.
Human Molecular Genetics|August 9, 2020
DOCK3 is a dosage-sensitive regulator of skeletal muscle and Duchenne muscular dystrophy-associated pathologiesAndrea L Reid, Yimin Wang, Adrienne Samani, et al.
Neuro-Oncology|March 12, 2015
Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627)Andrew B Lassman, Stephanie L Pugh, Mark R Gilbert, et al.
Nature Genetics|December 18, 2001
Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21Rachel V Baxter, Kamel Ben Othmane, Julie M Rochelle, et al.
Neuro-Oncology|January 30, 2021
Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825)Jeffrey S Wefel, Terri S Armstrong, Stephanie L Pugh, et al.
American Journal of Medical Genetics|July 18, 2000
Three probands with autistic disorder and isodicentric chromosome 15C M Wolpert, M M Menold, M P Bass, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|May 3, 2008
Refinement of 2q and 7p loci in a large multiplex NTD familyDemetra S Stamm, Deborah G Siegel, Lorraine Mehltretter, et al.
Cancers|January 16, 2020
Inhibition of PP2A with LB-100 Enhances Efficacy of CAR-T Cell Therapy Against GlioblastomaJing Cui, Herui Wang, Rogelio Medina, et al.
Pageof 146